Molecular Pathology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nicholson, J
Right arrow Articles by Ellison, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nicholson, J
Right arrow Articles by Ellison, D
J Clin Pathol: Mol Pathol 2000; 53:313-319
© 2000 Journal of Clinical Pathology

Imbalances of chromosome 17 in medulloblastomas determined by comparative genomic hybridisation and fluorescence in situ hybridisation

J Nicholson1, C Wickramasinghe2, F Ross3, J Crolla3 and D Ellison2

1 Department of Child Health, Southampton General Hospital, Southampton SO16 6YD, UK
2 Department of Pathology, Southampton General Hospital
3 Wessex Regional Genetics Laboratory, Salisbury District Hospital, SP2 8BJ, UK

Correspondence: Dr Ellison, Department of Pathology, Mail Point 02, Level E SPB, Southampton General Hospital, Southampton SO16 6YD, UK dwe{at}soton.ac.uk

Aims—To investigate the status of chromosome 17 in a series of medulloblastomas using comparative genomic hybridisation (CGH) and fluorescence in situ hybridisation (FISH).

Methods—Frozen tissue and formalin fixed, paraffin wax embedded tissue from 27 medulloblastomas were analysed by CGH and FISH, respectively. CGH ratio profiles for chromosome 17 were compared with the results of FISH, for which loss or gain of 17p or 17q was assessed in two distinct ways using a combination of differentially labelled subtelomeric and centromeric probes and analysing 200 nuclei in each tumour.

Results—CGH revealed imbalances consistent with isochromosome 17q in eight of 27 tumours. Either loss of 17p or gain of 17q was identified in a further nine tumours, whereas 10 tumours were apparently balanced. Using control results from preparations of paraffin wax embedded tonsils, thresholds for the detection of abnormalities by FISH were established, either by determining the dominant pattern of signals in each case, or the mean ratio of subtelomeric to centromeric signals. Results by CGH and FISH were concordant in 21 of 27 tumours. In the remainder, most discrepancies related to methodological differences.

Conclusions—CGH has a role in disclosing common, genome wide chromosomal gains or losses in tumours, the clinical relevance of which can then be studied in large archival series of paraffin wax embedded tumours using FISH.

Key Words: medulloblastoma • fluorescence in situ hybridisation • comparative genomic hybridisation




This article has been cited by other articles:


Home page
Cancer Res.Home page
J. G. Hodgson, T. Malek, S. Bornstein, S. Hariono, D. G. Ginzinger, W. J. Muller, and J. W. Gray
Copy Number Aberrations in Mouse Breast Tumors Reveal Loci and Genes Important in Tumorigenic Receptor Tyrosine Kinase Signaling
Cancer Res., November 1, 2005; 65(21): 9695 - 9704.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. M. Lamont, C. S. McManamy, A. D. Pearson, S. C. Clifford, and D. W. Ellison
Combined Histopathological and Molecular Cytogenetic Stratification of Medulloblastoma Patients
Clin. Cancer Res., August 15, 2004; 10(16): 5482 - 5493.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Molecular Pathology Journal of Clinical Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.